Moleculin Biotech, Inc.
MBRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $4 | $24 | $43 | $71 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $3 | $2 | $2 |
| Total Curr. Assets | $5 | $26 | $46 | $72 |
| Property Plant & Equip (Net) | $1 | $1 | $1 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $11 | $11 | $11 | $11 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $12 | $12 | $12 | $12 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $17 | $38 | $57 | $84 |
| Liabilities | – | – | – | – |
| Payables | $2 | $2 | $2 | $1 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $3 | $4 | $3 | $2 |
| Total Curr. Liab. | $5 | $7 | $5 | $4 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $5 | $5 | $0 | $1 |
| Total NC Liab. | $6 | $5 | $0 | $1 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $1 | $0 | $0 |
| Total Liabilities | $11 | $12 | $5 | $5 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$153 | -$132 | -$102 | -$73 |
| AOCI | -$0 | -$0 | $0 | $0 |
| Other Equity | $159 | $158 | $154 | $152 |
| Total Equity | $6 | $26 | $52 | $79 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $17 | $38 | $57 | $84 |
| Net Debt | -$4 | -$23 | -$43 | -$71 |